You are here

Onco-Innovations Limited

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ONCO
CSE Index: 
CSE25
Currency: 
CAD

Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.

Onco-Innovations Limited (ONCO)

1.44 Up
-0.01 (-0.69%)

Onco-Innovations Limited (ONCO)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Quote

Bid Size
1,900 
Bid Price
1.42 
Ask Price
1.45 
Ask Size
2,600 
Volume
76,200 
Last Price
1.44 
Tick
Up 
Net Change
-0.01 
Prev Close
1.45 
Open
1.44 
Day High
1.46 
Day Low
1.43 
52 Week High
2.80 
52 Week Low
0.56 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Bid Size
Bid Price
0.00 
Ask Price
0.00 
Ask Size
Volume
Last Price
2.48 
Tick
Up 
Net Change
 
Prev Close
2.48 
Open
0.00 
Day High
0.00 
Day Low
0.00 
52 Week High
 
52 Week Low
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quote

Bid Size
1,900 
Bid Price
1.42 
Ask Price
1.45 
Ask Size
2,600 
Volume
76,200 
Last Price
1.44 
Tick
Up 
Net Change
-0.01 
Prev Close
1.45 
Open
1.44 
Day High
1.46 
Day Low
1.43 
52 Week High
2.80 
52 Week Low
0.56 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Bid Size
Bid Price
0.00 
Ask Price
0.00 
Ask Size
Volume
Last Price
2.48 
Tick
Up 
Net Change
 
Prev Close
2.48 
Open
0.00 
Day High
0.00 
Day Low
0.00 
52 Week High
 
52 Week Low
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Depth Display By Order

Bid Broker Bid Size Bid Price Ask Price Ask Size Ask Broker
W.D. Latimer Co. Limited 1,000 1.42 1.45 1,200 Anonymous
Merrill Lynch Canada Inc. 900 1.42 1.45 1,400 Anonymous
Merrill Lynch Canada Inc. 1,100 1.41 1.46 1,000 Anonymous
CIBC World Markets Inc. 1,800 1.36 1.46 1,000 Anonymous
W.D. Latimer Co. Limited 1,000 1.35 1.46 500 Anonymous
Virtu Canada Corp. 400 1.32 1.46 1,500 Anonymous
National Bank Financial Inc. 500 1.30 1.47 1,000 Anonymous
W.D. Latimer Co. Limited 1,000 1.25 1.47 500 Anonymous
Anonymous 1,000 1.20 1.47 500 Anonymous
W.D. Latimer Co. Limited 1,000 1.05 1.47 1,400 Merrill Lynch Canada Inc.
Bid Broker Bid Size Bid Price Ask Price Ask Size Ask Broker
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Depth Display By Price

Bid Count Bid Size Bid Price Ask Price Ask Size Ask Count
2 1,900 1.42 1.45 2,600 2
1 1,100 1.41 1.46 4,000 4
1 1,800 1.36 1.47 3,400 4
1 1,000 1.35 1.48 4,100 4
1 400 1.32 1.49 3,000 4
Bid Count Bid Size Bid Price Ask Price Ask Size Ask Count
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Recent Trades

Date/Time Price Change Volume Buyer Seller Venue
Apr 25, 15:31 1.44 -0.01 5,000 Canaccord Capital Corporation CIBC World Markets Inc. CSE
Apr 25, 15:18 1.45 0.00 1,500 Anonymous Anonymous CSE
Apr 25, 15:18 1.45 0.00 900 Anonymous Anonymous CSE
Apr 25, 15:18 1.45 0.00 1,600 Anonymous Anonymous CSE
Apr 25, 15:18 1.45 0.00 1,000 Anonymous Anonymous CSE

Company Info

Address
1309-7th Street SW
Vancouver, BC V6C 2B5
Canada
Phone
(236) 521-0626
Email
nl@amalficorp.ca
Website
https://www.oncoinnovations.com
Listing date
Tuesday, November 26, 2024
Transfer Agent
Endeavor Trust Corporation

SEDAR Information

Filing Type Any News Releases Material Change Report Management's Discussion & Analysis Financial Statements
Timeframe 1 week1 month3 month6 month1 yearAll Time

Company Info

Address
1309-7th Street SW
Vancouver, BC V6C 2B5
Canada
Phone
(236) 521-0626
Email
nl@amalficorp.ca
Website
https://www.oncoinnovations.com
Listing date
Tuesday, November 26, 2024
Transfer Agent
Endeavor Trust Corporation

Capitalization

Issued & Outstanding: 
50243310
Reserved for Issuance: 
4954083

Company Officers

Thomas O'Shaughnessy, CEO
Nico Mah, CFO and Corporate Secretary

Bulletins

26/11/2024

2024-1133 - New Listing - Onco-Innovations Limited (ONCO)

Le 26 novembre/November 2024

The common shares of Onco-Innovations Limited have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.